CD44 and osteosarcoma: Consistently with the above observations, overexpression of CD44ICD in Cd44-negative osteosarcoma cells could partially re-establish the protein levels of MDR1 and significantly reduced the doxorubicin-induced levels of the apoptotic marker cleaved PARP1 (Figure 4B,D,F).